Impact of Antifibrotic Adherence and Dosing on Risk of Mortality and Hospitalization in Idiopathic Pulmonary Fibrosis

Journal:

Chest

Published:

2026-04-21

DOI:

10.1016/j.chest.2026.03.040

Affiliations:

8

Authors:

7

Go to article

Institutions	Authors	Share
Indiana University Indianapolis (IU Indianapolis), United States of America (USA)	3.750000	0.54
NYU Langone Hospital - Long Island, United States of America (USA)	1.000000	0.14
Mayo Clinic Health System, United States of America (USA)	1.000000	0.14
AbbVie, United States of America (USA)	1.000000	0.14
Regenstrief Institute, United States of America (USA)	0.250000	0.04

Interested in Cardiovascular Medicine and Haematology?